STEINMAN LAWRENCE 13D/13G Filings for Pasithea Therapeutics Corp. (KTTA)

STEINMAN LAWRENCE 13D and 13G filings for Pasithea Therapeutics Corp.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-06-07
6:29 pm
Purchase		 2023-06-02 13D Pasithea Therapeutics Corp.
KTTA		 STEINMAN LAWRENCE 78,859
6.000%		 78,859increase
(New Position)		 Filing